These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 36626821)
1. Multimorbidity and SARS-CoV-2-Related Outcomes: Analysis of a Cohort of Italian Patients. Catalano A; Dansero L; Gilcrease W; Macciotta A; Saugo C; Manfredi L; Gnavi R; Strippoli E; Zengarini N; Caramello V; Costa G; Sacerdote C; Ricceri F JMIR Public Health Surveill; 2023 Feb; 9():e41404. PubMed ID: 36626821 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
3. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy. Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317 [TBL] [Abstract][Full Text] [Related]
4. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study. Maximiano Sousa F; Roelens M; Fricker B; Thiabaud A; Iten A; Cusini A; Flury D; Buettcher M; Zukol F; Balmelli C; Zimmermann P; Troillet N; Vuichard-Gysin D; Schreiber PW; Bernhard-Stirnemann S; Tschudin-Sutter S; Nussbaumer-Ochsner Y; Sommerstein R; Gaudenz R; Marschall J; Senn L; Gardiol C; Keiser O; Schüpbach G; Wymann M; Vidondo B; Ch-Sur Study Group Swiss Med Wkly; 2021 Jul; 151():w20547. PubMed ID: 34324698 [TBL] [Abstract][Full Text] [Related]
5. Age differences in the association of comorbid burden with adverse outcomes in SARS-CoV-2. O'Hare AM; Berry K; Fan VS; Crothers K; Eastment MC; Dominitz JA; Shah JA; Green P; Locke E; Ioannou GN BMC Geriatr; 2021 Jul; 21(1):415. PubMed ID: 34229623 [TBL] [Abstract][Full Text] [Related]
6. The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy. Buscemi S; Davoli C; Trecarichi EM; Morrone HL; Tassone B; Buscemi C; Randazzo C; Barile AM; Colombrita P; Soresi M; Giannitrapani L; Cascio A; Scichilone N; Cottone C; Sbraccia P; Guglielmi V; Leonetti F; Malavazos AE; Basilico S; Carruba M; Santini F; Antonelli A; Viola N; Romano M; Cesana BM; Torti C J Infect Public Health; 2023 Apr; 16(4):520-525. PubMed ID: 36801631 [TBL] [Abstract][Full Text] [Related]
8. Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy. Raparelli V; Palmieri L; Canevelli M; Pricci F; Unim B; Lo Noce C; Villani ER; Rochon PA; Pilote L; Vanacore N; Onder G; Biol Sex Differ; 2020 Oct; 11(1):57. PubMed ID: 33066823 [TBL] [Abstract][Full Text] [Related]
9. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study. Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161 [TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and management of COVID-19 patients accessing the emergency department in a hospital in Northern Italy in March and April 2020. Caramello V; Maciotta A; De Salve AV; Gobbi V; Ruffino TM; Mazzetti G; Ricagni L; Ling C; Arione R; Boccuzzi A; Costa G; Sacerdote C; Ricceri F Epidemiol Prev; 2020; 44(5-6 Suppl 2):208-215. PubMed ID: 33412812 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak. Bottio T; Bagozzi L; Fiocco A; Nadali M; Caraffa R; Bifulco O; Ponzoni M; Lombardi CM; Metra M; Russo CF; Frigerio M; Masciocco G; Potena L; Loforte A; Pacini D; Faggian G; Onorati F; Sponga S; Livi U; Iacovoni A; Terzi A; Senni M; Rinaldi M; Boffini M; Marro M; Jorgji V; Carrozzini M; Gerosa G JACC Heart Fail; 2021 Jan; 9(1):52-61. PubMed ID: 33309578 [TBL] [Abstract][Full Text] [Related]
13. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)]. Cernigliaro A; Allotta AV; Scondotto S Epidemiol Prev; 2020; 44(5-6 Suppl 2):315-322. PubMed ID: 33412824 [TBL] [Abstract][Full Text] [Related]
14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
15. Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study. Tong L; Khani M; Lu Q; Taylor B; Osinski K; Luo J Obes Res Clin Pract; 2023; 17(1):47-57. PubMed ID: 36577559 [TBL] [Abstract][Full Text] [Related]
16. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A; JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385 [TBL] [Abstract][Full Text] [Related]
17. Statins and SARS-CoV-2 Infection: Results of a Population-Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces. McAlister FA; Wang T; Wang X; Chu A; Goodman SG; van Diepen S; Jackevicius CA; Kaul P; Udell J; Ko DT; Kwong JC; Austin PC; Lee DS; J Am Heart Assoc; 2021 Nov; 10(21):e022330. PubMed ID: 34689613 [TBL] [Abstract][Full Text] [Related]
18. Association between bisphosphonate use and COVID-19 related outcomes. Thompson J; Wang Y; Dreischulte T; Barreiro O; Gonzalez RJ; Hanč P; Matysiak C; Neely HR; Rottenkolber M; Haskell T; Endres S; von Andrian UH Elife; 2023 Aug; 12():. PubMed ID: 37534876 [TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933 [TBL] [Abstract][Full Text] [Related]
20. Patterns of multimorbidity and risk of severe SARS-CoV-2 infection: an observational study in the U.K. Chudasama YV; Zaccardi F; Gillies CL; Razieh C; Yates T; Kloecker DE; Rowlands AV; Davies MJ; Islam N; Seidu S; Forouhi NG; Khunti K BMC Infect Dis; 2021 Sep; 21(1):908. PubMed ID: 34481456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]